High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 825-828

  O'Donnell, J ^a,c   Tuddenham, E G D ^b   Manning, R ^a   Kemball Cook, G ^b   Johnson, D ^b   Laffan, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; FIBRINOGEN; VON WILLEBRAND FACTOR;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; CLINICAL ARTICLE; ERYTHROCYTE SEDIMENTATION RATE; GENE LOCUS; GENETIC LINKAGE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0031001874     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656061     Document Type: Article

References (13)

1. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345; 152-5.
2. Dahlbäck B, Carlsson M, Svenson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90; 1004-8.
3. Koster T, Rosendal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
4. Bertina RM, Koelman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Felden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
5. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
6. Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Brit J Haemal 1964; 10: 238-45.
7. Orstavik K, Magnus P, Reisner H, Berg K, Graham J, Nance W. Factor VIII and Factor IX in a Twin Population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
8. McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. (Letter) Thromb Haemost 1983; 50: 757.
9. Sodetz J, Paulson J, McKee P. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human factor VIII/von Willebrand factor. J Biol Chem 1979; 254: 10754-60.
10. Mohanty D, Ghosh K, Marwaha N, Kaur S, Chauhan A, Das KC. Major blood group antigens - a determinant factor of factor VIII levels in blood. (Letter) Thromb Haemost 1984; 51: 414.
11. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood groups on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
12. Figueiredo MS, Brownlee GG. CIS acting elements and transcription factors involved in the promoter activity of the human FVIII gene. J Biol Chem 1995; 270: 11828-38.
13. Kemball-Cook G, Tuddenham EGD. The Factor VIII mutation database on the world wide web: the Haemophilia A Mutation, Search Test and Resource Site. Hamsters update (v3.0) Nucleic Acids Res 1997; 25 (in press).